STOCK TITAN

Butterfly Network Inc - BFLY STOCK NEWS

Welcome to our dedicated page for Butterfly Network news (Ticker: BFLY), a resource for investors and traders seeking the latest updates and insights on Butterfly Network stock.

Overview

Butterfly Network Inc (symbol: BFLY) stands at the forefront of digital health by revolutionizing medical imaging through its innovative handheld ultrasound technology. Combining expertise in digital health, medical imaging, and handheld ultrasound systems, the company is dedicated to democratizing access to diagnostic imaging. By leveraging semiconductor technology and cloud-connected systems, Butterfly Network delivers solutions that are not only affordable and portable but also integrate intelligently into clinical workflows.

Cutting-Edge Technology

The foundation of Butterfly Network’s revolutionary products lies in its proprietary Ultrasound-on-Chip technology. This state-of-the-art semiconductor approach enables the production of a single handheld probe capable of whole-body imaging. The technology fundamentally transforms how ultrasound is applied in both routine and emergent care by replacing bulky, expensive ultrasound machines with a compact, easy-to-use device. The intelligent integration with a mobile application and cloud-connected software further enriches its usability, providing healthcare professionals with instant access to imaging data and remote guidance when needed.

Innovative Business Model and Market Position

Butterfly Network’s business model is markedly different from traditional medical device companies. The company focuses almost exclusively on product and intellectual property development, backed by a group of successful serial entrepreneurs. This unique approach allows for uninterrupted innovation and rapid iteration of its technology portfolio. Butterfly Network generates revenue primarily through the direct sales of its ultrasound devices and ancillary services such as software updates and educational tools. Its low-cost, high-performance products have redefined market expectations and disrupted the conventional imaging space.

Integration of AI and Cloud Connectivity

One of the hallmarks of Butterfly Network’s strategy is the seamless integration of artificial intelligence (AI) into its products. The incorporation of AI-driven applications, such as the ScanLab™ education tool, dramatically enhances the clinical utility of its devices. This AI-guided educational approach provides users with real-time anatomical labels, step-by-step instructions, and performance feedback. The intelligent software not only helps improve scanning proficiency among healthcare practitioners but also supports independent learning, making Butterfly Network an essential partner in modern medical education and clinical practice.

Transforming Medical Education and Clinical Training

Butterfly Network has played a pivotal role in elevating point-of-care ultrasound (POCUS) training. The company collaborates with leading academic institutions such as Kansas City University to integrate its AI-powered ScanLab™ into medical curricula. This initiative enables medical students to gain hands-on experience that is critical to their development as proficient clinicians. By offering a robust, interactive training platform, Butterfly Network ensures that upcoming healthcare professionals are well-versed in modern imaging techniques before entering residency or clinical practice.

Impact on Patient Care and Clinical Workflows

The combination of affordability, portability, and ease-of-use brings ultrasound imaging directly to the point-of-care. Healthcare providers can now perform real-time, whole-body imaging with devices that fit in their pockets. This capability not only enhances diagnostic speed and accuracy but also increases patient engagement by facilitating timely and precise treatment decisions. Butterfly Network’s solution removes the traditional barriers of cost and accessibility, enabling high-quality imaging in diverse settings ranging from urban hospitals to rural clinics and emergency scenarios.

Competitive Landscape and Industry Differentiation

Within the rapidly evolving digital health market, Butterfly Network distinguishes itself by integrating advanced semiconductor technology with intelligent software. While other companies in the medical imaging space may offer traditional ultrasound systems, Butterfly Network’s single-probe solution is unique in its capacity to deliver full-body imaging through a device that is both highly portable and cost-effective. This distinctive product offering not only serves a broad spectrum of clinical applications, including diagnostics in emergent and non-emergent scenarios, but also caters to veterinary medicine and other niche verticals. The emphasis on continuous product innovation and educational support further solidifies its standing among innovators in the field.

Collaboration and Ecosystem Development

Butterfly Network has cultivated a robust ecosystem that spans multiple disciplines, including computer science, physics, and electrical engineering. By drawing on diverse expertise, the company fosters an environment dedicated to continuous technological advancement and innovation. Its strategic partnerships with academic institutions, healthcare organizations, and industry innovators enhance its ability to refine and adapt its offerings to the evolving needs of the healthcare market. In addition, its educational initiatives and collaborative projects have built a network that not only supports clinical practice but also accelerates the adoption of new imaging technologies across global markets.

Comprehensive Approach to Digital Health

At the intersection of medical imaging and digital health, Butterfly Network is committed to both technological innovation and clinical excellence. Its portfolio merges hardware innovation with intelligent, cloud-enabled solutions, ensuring that every product released under its name delivers tangible benefits to healthcare professionals and patients alike. The company also emphasizes education and training as core components of its mission, ensuring that users are equipped to maximize the potential of its technology.

Commitment to Quality and User-Centric Design

Every aspect of Butterfly Network’s product development is underscored by a commitment to quality and usability. The devices are designed with the end-user in mind, enabling straightforward integration into existing clinical workflows and enhancing diagnostic efficacy without compromising on reliability. This pragmatic focus on user experience is reflected in the simple, intuitive interfaces and comprehensive support systems that accompany each product. Moreover, the continuous feedback loop from clinical educators and frontline practitioners helps refine the technology, ensuring it meets the high demands of modern healthcare environments.

Conclusion

Butterfly Network Inc is redefining the landscape of medical imaging with its innovative, handheld ultrasound solutions. Its integration of sophisticated semiconductor technology, AI-driven educational tools, and cloud-connected software creates a unique value proposition that transforms clinical practice and medical training. Through continuous collaboration with academic and healthcare institutions, the company is not only making high-quality ultrasound accessible but is also paving the way for the future of digital health. Its approach embodies a perfect blend of technological ingenuity and clinical pragmatism, making it a significant and enduring player in the field of medical imaging.

Rhea-AI Summary

Butterfly Network (NYSE: BFLY) announced that its Butterfly iQ3 ultrasound device was prominently featured in Episodes 12 and 13 of HBO Max's medical drama 'The Pitt'. The show depicts the device being used in critical trauma scenarios, particularly during a mass casualty event where traditional cart-based ultrasound equipment was replaced with Butterfly's handheld devices.

The episodes showcase the device's versatility in performing EFAST exams, blood flow evaluations, internal bleeding detection, and intracranial pressure assessments. CEO Joseph DeVivo highlighted that Butterfly devices are present in all top 100 U.S. health systems, indicating widespread adoption of the technology.

The unpaid product placement demonstrates Butterfly's growing recognition in healthcare, with the brand name becoming a verb among clinicians, according to VP of Marketing Jennifer Huang. The feature emphasizes the increasing role of Point-of-Care Ultrasound (POCUS) technology across medical specialties.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
5.41%
Tags
none
-
Rhea-AI Summary

Butterfly Network (NYSE: BFLY), a digital health company specializing in handheld whole-body ultrasound technology, has announced its participation in the upcoming Oppenheimer 35th Annual Healthcare MedTech & Services Virtual Conference on March 18, 2025.

The company's leadership, including Joseph DeVivo (President, CEO & Chairman) and Heather Getz (EVP & Chief Financial and Operations Officer), will engage in one-on-one investor meetings and participate in a Fireside Chat scheduled for 11:20am EDT. Investors can access the Fireside Chat webcast through the Events & Presentations section of Butterfly's investor website.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
5.28%
Tags
conferences
-
Rhea-AI Summary

Butterfly Network (NYSE: BFLY) reported strong Q4 2024 results with record quarterly revenue of $22.4 million, representing 35% year-over-year growth. The company achieved significant financial improvements, reducing Q4 net loss by 59% and net cash used in operations by 76%.

Key Q4 metrics include:

  • U.S. revenue up 32% to $14.5 million
  • International revenue increased 19% to $5.5 million
  • Product revenue grew 45% to $14.7 million
  • Gross margin improved to 61.4%

The company successfully completed a public offering in January 2025, raising $81.7 million in net proceeds. Looking ahead, Butterfly provided FY2025 guidance of $96-100 million in revenue (approximately 20% growth) and adjusted EBITDA loss of $37-42 million.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.95%
Tags
Rhea-AI Summary

Butterfly Network (NYSE: BFLY), a digital health company specializing in handheld whole-body ultrasound and intuitive software, has announced its participation in the TD Cowen 45th Annual Health Care Conference in Boston on March 3, 2025.

Heather Getz, Executive Vice President & Chief Financial and Operations Officer, will represent the company by conducting one-on-one investor meetings and delivering a business overview presentation scheduled for 1:10pm EST. Interested parties can access the presentation webcast through the Events & Presentations section of Butterfly's investor website.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.93%
Tags
conferences
-
Rhea-AI Summary

Butterfly Network (NYSE: BFLY), a digital health company specializing in portable, semiconductor-based ultrasound technology, has scheduled its fourth quarter and full year 2024 financial results announcement for February 28, 2025, at 8:00 am ET.

The company's President, CEO and Chairman Joseph DeVivo, along with EVP and CFO Heather Getz, will host a conference call and webcast before market opening. The event will be accessible via webcast on Butterfly's Investor Relations website, with telephone access available for both domestic (1-877-300-8521) and international (1-412-317-6026) callers.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.05%
Tags
conferences earnings
-
Rhea-AI Summary

Butterfly Network (NYSE: BFLY) has announced the pricing of an underwritten public offering of 24,000,000 shares of Class A common stock at $3.15 per share, expected to generate gross proceeds of approximately $75.6 million. The company has granted underwriters a 30-day option to purchase up to an additional 3,600,000 shares at the same price.

The proceeds will be used to fund the development and commercialization of new and existing products and services, as well as for general corporate purposes. The offering, managed by bookrunners TD Cowen, William Blair, and Lake Street Capital Markets, is expected to close on January 31, 2025.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
16.52%
Tags
Rhea-AI Summary

Butterfly Network (NYSE: BFLY) has announced the commencement of an underwritten public offering of Class A common stock. The company plans to grant underwriters a 30-day option to purchase up to an additional 15% of the shares sold in the offering. The net proceeds will be used to fund development and commercialization of new and existing products and services, as well as general corporate purposes.

TD Cowen, William Blair, and Lake Street Capital Markets are serving as bookrunners for the proposed offering, which is subject to market conditions. The offering is being made pursuant to a shelf registration statement on Form S-3 that became effective on August 22, 2023. A preliminary prospectus supplement and accompanying prospectus will be filed with the SEC.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
16.52%
Tags
-
Rhea-AI Summary

Butterfly Network (NYSE: BFLY) announced preliminary findings from a key study conducted with Rutgers Robert Wood Johnson Medical School, showing significant benefits of point-of-care ultrasound (POCUS) in hospital care. The study, presented at EchoEuro-Imaging Conference, focused on using cardiopulmonary POCUS for patients with unexplained shortness of breath.

The research compared hospital physicians using Butterfly iQ+ and iQ3 POCUS devices versus those not using POCUS. Key findings revealed substantial reductions in hospital length of stay (LOS): lower-acuity patients' LOS decreased from 6.7 to 5.6 days, while higher-acuity patients saw reduction from 39 to 16.7 days. Lower-acuity patients experienced up to 50% cost reduction. Daily lung ultrasound usage was identified as important for accelerating patient discharge.

The complete study is expected to be published in the first half of 2025.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-6.69%
Tags
none
-
Rhea-AI Summary

Butterfly Network (NYSE: BFLY) announced preliminary, unaudited Q4 2024 revenue growth of approximately 35% year over year. The digital health company, known for its portable semiconductor-based ultrasound technology, reported exceeding expectations with accelerating growth throughout 2024.

The company plans to release audited fourth quarter and full year 2024 results in late February 2025, along with guidance for 2025. Management expressed confidence in maintaining strong top-line growth with continued fiscal discipline going forward. The company will present a business update at the 43rd J.P. Morgan Healthcare Conference on January 16, 2025.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.99%
Tags
Rhea-AI Summary

Butterfly Network (NYSE: BFLY), a digital health company specializing in handheld whole-body ultrasound technology, has announced its participation in the 43rd Annual J.P. Morgan Healthcare Conference. The conference will take place from January 13-16, 2025, at the Westin St. Francis in San Francisco.

President, CEO & Chairman Joseph DeVivo and EVP & CFO Heather Getz will present on January 16, 2025, at 7:30 AM PST. The presentation will be available via webcast on the Events & Presentations section of Butterfly's investor website and will remain accessible for replay until February 15, 2025.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
6.19%
Tags
conferences

FAQ

What is the current stock price of Butterfly Network (BFLY)?

The current stock price of Butterfly Network (BFLY) is $2.46 as of April 11, 2025.

What is the market cap of Butterfly Network (BFLY)?

The market cap of Butterfly Network (BFLY) is approximately 556.3M.

What is Butterfly Network's core technology?

Butterfly Network utilizes proprietary Ultrasound-on-Chip technology to deliver handheld, whole-body ultrasound imaging. This semiconductor-based approach enables compact, affordable, and high-performance medical imaging.

How does Butterfly Network generate revenue?

The company primarily generates revenue through the direct sales of its ultrasound devices and complementary services, including software and educational tools that support clinical training and practice.

What makes Butterfly Network's ultrasound technology unique?

Its unique integration of semiconductor technology with cloud-connected, AI-powered software allows a single handheld device to deliver high-quality, full-body imaging that is both accessible and easy to use in various clinical settings.

How is Butterfly Network positioned within the digital health market?

Butterfly Network differentiates itself by focusing solely on product and intellectual property development, leveraging advanced technology and strategic partnerships to revolutionize medical imaging and point-of-care diagnostics.

What role does AI play in Butterfly Network's solutions?

AI is integral to the company’s offerings, enhancing clinical workflows through real-time scanning guidance, anatomical labeling, and performance feedback via tools like the ScanLab™ application, which improves both user proficiency and diagnostic accuracy.

How does Butterfly Network support medical education?

The company collaborates with educational institutions to integrate its handheld ultrasound and AI-driven training tools into medical curricula, enabling students to gain practical, hands-on experience that prepares them for clinical practice.

Who are Butterfly Network's main competitors in the market?

While several companies operate within the medical imaging space, Butterfly Network distinguishes itself by combining advanced semiconductor technology with AI and cloud connectivity, setting it apart from traditional ultrasound providers.

What market segments does Butterfly Network serve?

Butterfly Network serves a broad spectrum of market segments including clinical diagnostics, point-of-care assessments, medical education, and even veterinary applications, ensuring its technology is applicable across diverse healthcare settings.
Butterfly Network Inc

NYSE:BFLY

BFLY Rankings

BFLY Stock Data

556.29M
184.42M
14.88%
29.79%
5.07%
Medical Devices
X-ray Apparatus & Tubes & Related Irradiation Apparatus
Link
United States
BURLINGTON